港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

長風藥業

20.240

-0.140-0.69%

成交量：4.55萬

成交額：92.41萬

市值：83.19億

市盈率：2,648.52

高：20.660

開：20.360

低：20.040

收：20.380

52周最高：48.800

52周最低：18.100

股本：4.11億

香港流通股本：3.02億

量比：0.13

換手率：0.02%

股息：- -

股息率：- -

每股收益(LYR):0.008

淨資產收益率：0.21%

總資產收益率：-0.83%

市淨率：4.89

市盈率(LYR):2,648.52

市銷率: 16.61

資料載入中...

總覽公司新聞資訊公告

長風藥業(02652)股價下跌5.036%，現價港幣$23.76

阿斯达克财经

重磅產品獲批臨床！500億過敏性鼻炎用藥市場將迎變局

長風藥業盤中異動早盤股價大漲5.32%

長風藥業03月09日主力淨流出120.1萬元散户資金買入

港股公告掘金 | 蒙牛乳業預計年度股東應占利潤將約為14億元至 16億元

長風藥業(02652)奧洛他定莫米松鼻噴霧劑臨床試驗申請獲NMPA批准

智通财经网

長風藥業獲NMPA批准開展鹽酸奧洛他定與糠酸莫米松一水合物鼻噴霧劑臨床試驗

長風藥業(02652)獲納入滬港通及深港通的港股通標的證券名單

長風藥業(02652)2月股份變動月報：回購327,500股轉為庫存股，總股本維持411,978,387股

長風藥業（02652）回購3.05萬股股份，總額約118萬港元

長風藥業(02652)2月27日斥資118.01萬港元回購3.05萬股

長風藥業（02652）回購43,000股股份，總額約164萬港元

長風藥業（02652）回購33,000股股份，總金額1,232,250港元

長風藥業(02652)2月25日斥資123.23萬港元回購3.3萬股

長風藥業午前升逾4% 自研ICF004新藥臨床試驗申請獲受理

長風藥業（HKEX: 2652.HK）宣佈NMPA受理潛在同類首創吸入乾粉製劑ICF004的新藥臨床試驗申請，該藥針對PF-ILD領域未滿足的臨床需求

長風藥業(02652)2月24日斥資99.74萬港元回購2.7萬股

長風藥業(02652)：國家藥監局受理ICF004的IND申請

長風藥業於2月20日斥資29.03萬港元回購8000股

長風藥業（02652）回購8,000股股份，總額約29萬港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02652/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"長風藥業","latestPrice":20.24,"timestamp":1780459500006,"preClose":20.38,"halted":0,"volume":45500,"delay":0,"changeRate":-0.006869479882237516,"floatShares":302000000,"shares":411000000,"eps":0.007641686061546418,"marketStatus":"午間休市","change":-0.14,"latestTime":"06-03 12:05:00","open":20.36,"high":20.66,"low":20.04,"amount":924080,"amplitude":0.030422,"askPrice":20.24,"askSize":3000,"bidPrice":20.08,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.007641686061546418,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1780462800000},"marketStatusCode":3,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":20.38,"openAndCloseTimeList":[[1780450200000,1780459200000],[1780462800000,1780473600000]],"volumeRatio":0.127386,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":302000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.007642,"volumeRatio":0.127386,"shares":411000000,"dividePrice":0,"high":20.66,"amplitude":0.030422,"preClose":20.38,"low":20.04,"week52Low":18.1,"pbRate":"4.89","psRate":"16.61","week52High":48.8,"institutionHeld":0,"latestPrice":20.24,"committee":-0.5,"eps":0.007642012710702224,"divideRate":0,"volume":45500,"delay":0,"ttmEps":0.007642012710702224,"open":20.36,"prevYearClose":35,"prevWeekClose":22.22,"prevMonthClose":22.22,"prevQuarterClose":22.16,"fiveDayClose":19.66,"twentyDayClose":22.02,"sixtyDayClose":37.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-06-01","current":2664.532989,"percent":0.839744,"low":-293.764894,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"high":3595.964728,"avg":1098.551773,"sd":1175.771413,"marketCap":8746652155},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-01","current":3038.815931,"twenty":400.575047,"median":467.575731,"eighty":2963.886694,"marketCap":8746652155}],"updateTime":1780417555810},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619157827","title":"長風藥業(02652)股價下跌5.036%，現價港幣$23.76","url":"https://stock-news.laohu8.com/highlight/detail?id=2619157827","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619157827?lang=zh_tw&edition=fundamental","pubTime":"2026-03-13 11:35","pubTimestamp":1773372900,"startTime":"0","endTime":"0","summary":"[下跌股]长风药业(02652) 股价在上午11:35比前收市价下跌5.036%，现股价为港币$23.76。至目前为止，今日最高价为$25.0，而最低价为$23.76。总成交量为25.5万股，总成交金额为港币$619.089万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603131799/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2603131799/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618490799","title":"重磅產品獲批臨床！500億過敏性鼻炎用藥市場將迎變局","url":"https://stock-news.laohu8.com/highlight/detail?id=2618490799","media":"制药网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618490799?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 16:38","pubTimestamp":1773218312,"startTime":"0","endTime":"0","summary":"在高频复发且患者规模庞大等特征下，过敏性鼻炎催生了百亿元规模的药物市场。有数据显示，2024年—2028年，我国过敏性鼻炎用药行业市场规模由432.75亿元增长至500.9亿元。此外，该产品将与公司现有的过敏性鼻炎及慢性鼻窦炎产品组合形成互补，进一步增强公司在国内及全球市场的竞争优势。未来，随着国产创新产品不断涌现、研发技术持续迭代，我国过敏性鼻炎用药市场将迎来更广阔的发展空间，将为患者带来健康福音。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311164011a6b79a35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311164011a6b79a35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618941886","title":"長風藥業盤中異動 早盤股價大漲5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618941886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618941886?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 09:51","pubTimestamp":1773193900,"startTime":"0","endTime":"0","summary":"2026年03月11日早盘09时51分，长风药业股票出现异动，股价急速拉升5.32%。截至发稿，该股报29.700港元/股，成交量15.85万股，换手率0.05%，振幅5.32%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。长风药业股票所在的药品行业中，整体跌幅为0.08%。其相关个股中，宝济药业-B、君圣泰医药-B、长风药业涨幅较大，振幅较大的相关个股有宝济药业-B、开拓药业-B、李氏大药厂，振幅分别为8.56%、7.41%、7.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311095140a6b6ad4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311095140a6b6ad4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618675399","title":"長風藥業03月09日主力淨流出120.1萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618675399","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618675399?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 16:15","pubTimestamp":1773044116,"startTime":"0","endTime":"0","summary":"03月09日, 长风药业股价跌13.39%，报收29.50元，成交金额5641.4万元，换手率0.63%，振幅27.01%，量比6.62。长风药业今日主力资金净流出120.1万元，上一交易日主力净流出0万元。该股近5个交易日下跌26.62%，主力资金累计净流出157.1万元；近20日主力资金累计净流出77.6万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161553a6b1b2f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309161553a6b1b2f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618369053","title":"港股公告掘金 | 蒙牛乳業預計年度股東應占利潤將約為14億元至 16億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618369053","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618369053?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 09:03","pubTimestamp":1773018197,"startTime":"0","endTime":"0","summary":"重大事项：恒瑞医药(01276)：阿得贝利单抗注射液获得药物临床试验批准通知书安井食品(02648)拟向河南子公司增资1.2亿元轩竹生物-B(02575)获纳入港股通股票名单派格生物医药-B(02565)：派格生物新一代GLP-1(CR059)首次人体试验取得一个月临床观察结果长风药业(02652)获纳入沪港通及深港通的港股通标的证券名单滨海投资(02886)获提供不超过4500万美元及1.73亿","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411397.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B0169L03.USD","LU0251143458.SGD","LU0348788117.USD","LU1769817179.HKD","IE0032834883.USD","HK0000320264.USD","LU1769817096.USD","LU0163747925.USD","VT","IE00B29SXG58.USD","LU0315179316.USD","LU0594300419.USD","LU0823426308.USD","LU2045819591.USD","VXUS","IE00B031HY20.USD","LU0128522157.USD","LU0359201612.USD","BK1521","LU0651946864.USD","IE0008368742.USD","LU0211977185.USD","LU0287142896.SGD","LU0672654166.SGD","HK0000306701.USD","BK1597","02652","LU0370786039.SGD","LU0259732245.USD","LU0588546209.SGD","LU0072462343.USD","LU0029875118.USD","BK1237","LU1115378108.SGD","IE00B97KM107.HKD","BK1553","BK1191","IE00B031J352.USD","SG9999002828.SGD","LU0737861699.HKD","LU0307460666.USD","LU0359201885.HKD","LU0650527681.SGD","LU0106959298.USD","02575","LU1048588211.SGD","LU1224709979.USD","02319","LU2125910500.SGD","IE0009570106.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618469288","title":"長風藥業(02652)奧洛他定莫米松鼻噴霧劑臨床試驗申請獲NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2618469288","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618469288?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 07:48","pubTimestamp":1773013699,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，奥洛他定莫米松鼻喷雾剂的临床试验申请已获中华人民共和国国家药品监督管理局批准。公司是中国首家就该产品提交仿制药临床试验申请的企业。该CTA的获批标志着推进该产品进入临床试验阶段的里程碑。该产品的进展进一步印证了集团在复杂鼻喷雾制剂及药械整合方面的执行能力。集团将与NMPA保持积极沟通，并按照监管要求推进后续临床活动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"长风药业(02652)奥洛他定莫米松鼻喷雾剂临床试验申请获NMPA批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122463913","title":"長風藥業獲NMPA批准開展鹽酸奧洛他定與糠酸莫米松一水合物鼻噴霧劑臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1122463913","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122463913?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 07:45","pubTimestamp":1773013520,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司宣布，其研发的盐酸奥洛他定与糠酸莫米松一水合物鼻喷雾剂已获得国家药品监督管理局（NMPA）的临床试验申请批准。这一进展标志着该药物正式进入临床研究阶段，为公司产品管线增添了重要一员。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617806662","title":"長風藥業(02652)獲納入滬港通及深港通的港股通標的證券名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2617806662","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617806662?lang=zh_tw&edition=fundamental","pubTime":"2026-03-08 18:41","pubTimestamp":1772966488,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，根据上海证券交易所及深圳证券交易所发布的港股通标的证券名单调整公告，本公司H股已正式获纳入沪港通及深港通下的港股通标的证券名单，有关调整自2026年3月9日起生效。自生效日起，符合港股通准入条件的中国内地投资者将可透过沪港通及深港通下的港股通机制，交易本公司于香港联合交易所有限公司上市的H股。董事会预期，是次纳入将有助于扩大本公司的股东基础，提升本公司H股的交易流动性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1411331.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","BK4588","VXUS","02652","BK1191","VT","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189454115","title":"長風藥業(02652)2月股份變動月報：回購327,500股轉為庫存股，總股本維持411,978,387股","url":"https://stock-news.laohu8.com/highlight/detail?id=1189454115","media":"公告速递","labels":["buyback","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189454115?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 16:43","pubTimestamp":1772441020,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年3月2日发布截至2026年2月28日的股份变动月报。公告显示，公司本月对H股进行回购并将回购股份转为库存股，整体股本规模保持不变。报告期内，H股回购数量为327,500股，完成后公司H股已发行股数变动为301,727,086股，库存股数增至496,500股；内资股数量109,754,801股保持不变。公司注册股本合计人民币411,978,387元。该公告由执行董事及联席公司秘书朱玉玉签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111489921","title":"長風藥業（02652）回購3.05萬股股份，總額約118萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111489921","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111489921?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 19:06","pubTimestamp":1772190361,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月27日发布翌日披露报表，公告显示公司当日于香港联交所回购30,500股H股，占回购前已发行股份约0.0101%。回购价格区间为每股38.24港元至38.92港元，合计动用金额约118万港元。回购后，公司已发行股份总数调整为301,727,086股，库藏股数量为496,500股，整体发行股本总数维持在302,223,586股。公司确认已遵守上市规则及相关法律。公告由执行董事及联席公司秘书朱玉玉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614183243","title":"長風藥業(02652)2月27日斥資118.01萬港元回購3.05萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614183243","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614183243?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 19:03","pubTimestamp":1772190212,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年2月27日斥资118.01万港元回购3.05万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107844057","title":"長風藥業（02652）回購43,000股股份，總額約164萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107844057","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107844057?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 17:51","pubTimestamp":1772099500,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月26日发布翌日披露报表，公告公司当日通过香港联交所回购43,000股H股。每股价格在37.88港元至38.48港元之间，本次交易总额约164万港元。回购后，公司已发行股本降至301,757,586股，库存股增至466,000股，合计股本仍为302,223,586股。本次回购依据2025年12月16日股东大会批准的购回授权进行，可回购股份总数为30,222,358股。截至目前，公司已累计回购466,000股。公告由执行董事及联席公司秘书朱玉玉签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108164494","title":"長風藥業（02652）回購33,000股股份，總金額1,232,250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108164494","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108164494?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 18:56","pubTimestamp":1772016985,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月25日发布翌日披露报表，宣布通过香港联合交易所回购股份。根据公告，本次回购数量为33,000股，占回购前已发行股份约0.0109%。本次股份回购价格区间为每股36.64港元至37.9港元，合计支付1,232,250港元。回购完成后，公司已发行股份数量变更为301,800,586股，库藏股数量增至423,000股，合计股份数保持在302,223,586股。公司于2025年12月16日通过该回购授权，可回购上限为30,222,358股，截至公告日已累计回购423,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614083686","title":"長風藥業(02652)2月25日斥資123.23萬港元回購3.3萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2614083686","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614083686?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 18:52","pubTimestamp":1772016766,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，于2026年2月25日，该公司斥资123.23万港元回购3.3万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614761567","title":"長風藥業午前升逾4% 自研ICF004新藥臨床試驗申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2614761567","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614761567?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 11:25","pubTimestamp":1771989900,"startTime":"0","endTime":"0","summary":"　　长风药业盘中涨超5%，截至发稿，股价上涨4.16%，现报38.52港元，成交额1386.42万港元。　　2月24日，长风药业发布公告，本公司自主研发的吸入粉雾剂候选药物ICF004（产品）的新药临床试验申请（该申请）已获中国国家药品监督管理局受理。锚定PF-ILD未满足需求，ICF004的研发逻辑立足于“疗效—耐受性”临床矛盾，在现有治疗基础上探索新的递送与作用路径，以期改善治疗窗口和患者获益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-02-25/doc-inhnyyvu2366690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146441020","title":"長風藥業（HKEX: 2652.HK）宣佈NMPA受理潛在同類首創吸入乾粉製劑ICF004的新藥臨床試驗申請，該藥針對PF-ILD領域未滿足的臨床需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1146441020","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146441020?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 11:13","pubTimestamp":1771989225,"startTime":"0","endTime":"0","summary":"长风药业（香港交易所代码：2652.HK）宣布，其潜在同类首创（First-in-Class）吸入干粉制剂候选药物ICF004的新药临床试验（IND）申请，已获得国家药品监督管理局（NMPA）的受理。ICF004旨在针对进行性纤维化性间质性肺病（PF-ILD）领域存在的未满足临床需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613794808","title":"長風藥業(02652)2月24日斥資99.74萬港元回購2.7萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613794808","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613794808?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 17:49","pubTimestamp":1771926563,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业(02652)发布公告，该公司于2026年2月24日斥资99.74万港元回购2.7万股股份，每股回购价格为36.6-37.18港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613753336","title":"長風藥業(02652)：國家藥監局受理ICF004的IND申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2613753336","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613753336?lang=zh_tw&edition=fundamental","pubTime":"2026-02-24 06:12","pubTimestamp":1771884770,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，本公司自主研发的吸入粉雾剂候选药物ICF004(产品)的新药临床试验申请(该申请)已获中国国家药品监督管理局受理。ICF004拟用于治疗进行性纤维化间质性肺病，该疾病领域包括特发性肺纤维化及进行性肺纤维化等危及生命的适应症。在已完成的临床前研究中，ICF004经吸入给药后呈现差异化的分布特征，表现为肺组织高暴露量及低全身暴露量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IND","BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613458226","title":"長風藥業於2月20日斥資29.03萬港元回購8000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2613458226","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613458226?lang=zh_tw&edition=fundamental","pubTime":"2026-02-22 12:56","pubTimestamp":1771736160,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　长风药业（02652）发布公告，于2026年2月20日斥资29.03万港元回购8000股。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-02-22/doc-inhnsisp8136313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158015190","title":"長風藥業（02652）回購8,000股股份，總額約29萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158015190","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158015190?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 18:09","pubTimestamp":1771582157,"startTime":"0","endTime":"0","summary":"长风药业股份有限公司于2026年2月20日公告，基于翌日披露报表显示，公司于同日回购8,000股H股股份，约占当日前已发行股本的0.0027%。回购价介乎每股36.08港元至36.50港元，支付总额约290,260港元。公司已发行股本由此减少至301,860,586股，库藏股数目相应增至363,000股，合计已发行股份和库藏股总数为302,223,586股。该项回购依据2025年12月16日通过的购回授权进行，授权购回上限为30,222,358股。长风药业股份有限公司确认已遵守香港联交所上市规则以及相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":149,"code":"91000000","status":"200"}]}}